SCHEMBL6001096

SCHEMBL6001096

CC(C)CCC1(C(=O)O)CCN(Cc2nc(-c3ccc(NCCc4ccc(C5CCCCC5)cc4)cc3)cs2)CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSL P07711 3/20 0.39
CTSB P07858 3/20 0.39
CTSS P25774 3/20 0.39
MRE11 P49959 1/20 0.35
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
NPC1 O15118 1/20 0.35
POLB P06746 1/20 0.35
RAB9A P51151 1/20 0.35
MAPK1 P28482 1/20 0.35
P2RX3 P56373 2/20 0.34
ALOX5 P09917 1/20 0.34
TRPA1 O75762 1/20 0.34
CTSK P43235 1/20 0.33
S1PR4 O95977 1/20 0.33
S1PR1 P21453 1/20 0.33
S1PR3 Q99500 1/20 0.33
S1PR5 Q9H228 1/20 0.33
HTT P42858 1/20 0.33
MMP2 P08253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6001092 0.85 CTSL (0.38) CTSLCTSBCTSSMRE11MEN1
SCHEMBL6000920 0.84 MEN1 (0.39) CTSLCTSBCTSSMRE11MEN1
SCHEMBL6000650 0.83 MAPK1 (0.40) CTSLCTSBCTSSMRE11MEN1
SCHEMBL6000571 0.83 S1PR1 (0.42) CTSLCTSBCTSSMRE11MEN1
SCHEMBL5999100 0.81 S1PR1 (0.44) MRE11MEN1KMT2ANPC1POLB
SCHEMBL5999925 0.78 PTPN2 (0.39) MRE11MEN1KMT2ANPC1POLB
SCHEMBL6001034 0.77 RAB9A (0.41) MRE11MEN1KMT2ANPC1POLB
SCHEMBL6001067 0.76 RAB9A (0.42) MRE11MEN1KMT2ANPC1POLB
SCHEMBL6000824 0.75 RORC (0.37) MRE11MEN1KMT2ANPC1POLB
SCHEMBL6000064 0.74 NPC1 (0.41) MRE11MEN1KMT2ANPC1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-06-08 US claimed
EP-1553091-A1 HETEROAROMATIC PENTACYCLIC COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2005-07-13 EP claimed
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-06-08 US disclosed
EP-1553091-A1 HETEROAROMATIC PENTACYCLIC COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2005-07-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof PTPN11, PTPN1, PTPN3 CTSL 4264/4885CTSB 1634/4885CTSS 2354/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.